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Rotavirus is an important causative agent of acute diarrhea in infants and young children worldwide [1]. Among the leading causes of death, diarrhea is the second 
most common cause of child death [2]. Approximately 40% of 
hospitalizations in cases of acute diarrhea in under 5 year children 
are caused by rotavirus and every year nearly half a million children 
die due to rotavirus infections [3]. According to Global Enteric 
Multicenter Study, the four most common pathogens responsible 
for moderate-to-severe diarrhea among children in sub-Saharan 
Africa and South Asia were rotavirus, Cryptosporidium, 
enterotoxigenic Escherichia coli, and Shigella [4].
In developing countries of Asia, Africa, and Latin America 
where hygiene and sanitary measures are suboptimal, and access 
to health-care facilities are meager, mortality rate due to rotavirus-
associated diarrhea is high [5]. Rotavirus diarrhea accounts for 
2,000,000 outpatient visits, 457,000–884,000 hospitalizations, 
and 122,000–153,000 deaths in under-5 children in India, 
annually. There is a huge economic impact of rotavirus diarrhea. 
It is estimated that India spends Rs 2.0–3.4 billion (US$ 41–72 
million) annually in medical costs to treat rotavirus diarrhea [6]. 
Besides improvement in hygiene and sanitation, vaccination plays 
an important role to decrease the incidence of severe rotavirus-
associated diarrhea requiring admission in the hospital, thereby 
decreasing the disease burden. Two live-attenuated rotavirus 
vaccines (Rotarix® and RotaTeq®) have demonstrated very good 
safety and efficacy profiles in large clinical trials in the Western 
industrialized countries and Latin America [7-12]. In 2009, the 
World Health Organization recommended that rotavirus vaccine 
be included in all national immunization programme [6].
The objectives of this study were to study the clinical profile 
and demographic data of rotavirus-associated diarrhea, among 
children visiting a tertiary care center and to provide background 
knowledge on the disease before the introduction of the vaccine 
in that area.
MATERIALS AND METHODS
The current observational study was performed at a tertiary care 
hospital in Northern India. After getting the Ethical Committee 
approval and informed consent from the parents, all the children 
<5 years of age with acute diarrhea were included in the study. 
A total of 7500 patients with acute diarrhea attended the 
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pediatrics department through outpatient department as well 
as through emergency during the study period of 1 year, out 
of which 5300 patients were in the age group of under 5 years 
(5300/7500, i.e., 71%). Out of these 5300 patients, 4100 satisfied 
the inclusion criteria. Due to limitations in the availability of the 
Latex agglutination test (LAT) kit, only 210 patients who satisfied 
the inclusion criteria, could be recruited in the study on the basis 
of systematic random sampling.
Acute diarrhea was defined as the passage of three or more 
watery or loose stools per day for at least 3 days. Children with 
dysentery, congenital malformations (cleft lip, cleft palate, 
etc.) or documented significant background diseases such as 
immunodeficiency syndrome or taking immunosuppressant drugs 
and those who had received rotavirus vaccine were excluded 
from the study. The patients were subjected to detailed history 
including demographic details and clinical examination including 
nutritional assessment. Nutrition was assessed by weight for age, 
height for age, and wasting (weight for height irrespective of 
age) [13].
Follow-up of the indoor patients was made until their discharge 
and follow-up of outdoor patients was made telephonically. 
A single fresh stool sample was obtained in a sterile container 
at the time of the first contact and subsequently stored frozen at 
−20°C until transferred (every fortnightly) to the Microbiology 
Laboratory at Sher-e-Kashmir University of Agricultural Sciences 
and Technology. The samples were transported in a cold chain box 
to maintain the requisite ambient temperature. The samples were 
analyzed using LAT which was performed using HiRotavirus 
Latex Test kit (HiMedia, Mumbai) as per the manufacturer’s 
instructions. This is a rapid card test in which latex particles are 
coated with antibodies specific for rotavirus antigens present in a 
fecal supernatant. This test is read with the naked eye for 5 min. 
LAT is a simple, sensitive, and rapid test, and it is the laboratory 
test of choice in screening stool specimens of rotavirus suspected 
diarrhea patients. The sensitivity, specificity, and accuracy of LA 
are 69%, 100%, and 93%, respectively [14].
Numerical variables were reported in terms of mean and SD. 
Categorical variables were reported in terms of numbers and 
percentages. Association of each of the categorical variable with 
response variable was assessed by Chi-square test, and the strength 
of their association was computed by unadjusted odds ratio. All 
the data were analyzed using computer software Microsoft Excel 
and SPSS ver. 12.0 for Windows.
RESULTS
Out of 210 patients who were subjected to LAT, 108 (51.4%) 
were tested positive for rotavirus gastroenteritis (RVGE) and 
102 (48.6%) were tested negative for RVGE. Out of 210 patients, 
170 (80.9%) were hospitalized and 40 (19.1%) were managed on 
an outdoor basis. Among the admitted patients, 54.1% (92) had 
RVGE as against 40% (16) of those managed on an outdoor basis. 
The mean age of the studied patients was 20.73±14.15 months. 
The frequency of RVGE was highest in the age group of 2–3 years, 
constituting 86.4% (32/37) of the total patients in this age group 
(Chi-square value=3.40, p=0.06), (Table 1).
Overall, a male predominance was observed in both the 
RVGE and Non RVGE (NRVGE) group. The male to female 
ratio in RVGE group was 1.34. Although male children seem 
to suffer more from diarrhea, the difference was statistically 
insignificant. Rotavirus-associated diarrhea was detected in 
48.9% of the patients belonging to rural areas and 53.1% of the 
patients belonging to urban areas. The incidence of RVGE was 
maximum during winters, i.e., December (100%) followed by 
January (92.8%) and February (93.7%) (Table 2).
In the current study, 52.5% of the patients with piped water 
supply had RVGE while the figure for well water and natural 
sources were 47.8% and 33.3%, respectively. Out of 210 admitted 
patients, 85.7% (180) patients with gastroenteritis had access to 
the sanitary lavatory as compared to 14.3% (30) patients with no 
access to sanitary lavatory. 50% (15) of the patients who did not 
have any access to sanitary lavatory had RVGE. The differences 
were statistically insignificant.
None of the exclusive breastfed patients had RVGE. Total 
75% of the patients with RVGE were top fed and 25% were 
on mixed feeding. Total 59% of the patients with inadequate 
complementary feeding had RVGE. In this study, 34.8% of the 
patients with normal nutritional status had RVGE, whereas 79.5% 
Table 1: Age-wise distribution of the patients (n=210)
Age (in years) RVGE NRVGE Total
No. (%) No. (%)
0–1 36 (43.9) 46 (56.1) 82
1–2 28 (45.2) 34 (54.8) 62
2–3 32 (86.4) 5 (13.6) 37
3–4 7 (10.9) 16 (89.1) 23
4–5 5 (83.3) 1 (16.7) 6
Total 108 (51.4) 102 (48.6) 210
Chi-square value, 3.50; p=0.06 (Non-significant), NRVGE: Non RVGE, RVGE: 
Rotavirus gastroenteritis
Table 2: Distribution of patients according to the month of 
admission
Month RVGE NRVGE Total
No. (%) No.(%) No. (%)
January 26 (92.8) 2 (7.2) 28 (13.3)
February 15 (93.7) 1 (6.3 16 (7.6)
March 4 (40.0) 6 (60.0) 10 (4.7)
April 2 (20) 8 (80) 10 (4.7)
May 2 (33.3) 4 (66.7) 6 (2.8)
June 2 (5.2) 36 (94.8) 38 (18.1)
July 2 (6.3) 30 (93.7) 32 (15.2)
August 16 (76.1) 5 (23.9) 21 (10.0)
September 12 (75.0) 4 (25.0) 16 (7.6)
October 2 (28.6) 5 (71.4) 7 (3.3)
November 1 (20.0) 4 (80.0) 5 (2.3)
December 24 (100.0) 0 (0) 24 (11.4)
Total 108 (51.4) 102 (48.6) 210 (100.0)
NRVGE: Non RVGE, RVGE: Rotavirus gastroenteritis
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of the patients who were malnourished had RVGE (Chi-square 
value for linear trend=26.28, p<0.0001). There was a statistically 
significant difference between the severity of dehydration between 
RVGE and NRVGE group. Among the patients with RVGE, 10.2% 
had no dehydration, 54.6% had some dehydration, and 35.2% had 
severe dehydration. The average duration of gastroenteritis in 
patients with RVGE was 4.30±0.91 days. Table 3 represents the 
clinical symptoms related to diarrhea.
DISCUSSION
The present study was conducted to assess the burden of RVGE in 
children under 5 years of age in the Northern region of India. In 
our study, the hospital-based frequency of RVGE in children under 
5 years of age was observed as 51.4% (108/210). Singh et al. [15] 
conducted a study in Amritsar on 50 consecutive children, aged 
6 months–3 years with diarrhea over a period of 1 year and 
reported a prevalence rate of 44%. Shariff et al. [16] reported a 
prevalence rate of 38.7% in under five children in Eastern Nepal. 
Mathew et al. [17] in Ernakulam district, Kerala also detected 
rotavirus in 36% of diarrhea-related hospital admissions among 
children <5 years of age. Sarangi et al. [18] in her study in a 
tertiary care hospital of Eastern India reported a prevalence rate 
of 48% in under 5-year children.
The quantum of hospitalized patients in the present study was 
high as compared to outdoor patients, which could be explained 
on the basis of the fact that this study was conducted in an apex 
referral tertiary care hospital catering to nine districts and its 
neighboring states. However, the observed prevalence of RVGE 
in indoor (54.1%) and outdoor (40%) patients has been similar to 
that reported by Ahmed et al. [19].
As observed in the other parts of the world, the burden of 
rotavirus disease is predominantly borne by children <2 years 
of age [20]. In our study, maximum cases (88.9%) of RVGE 
occurred in the age group of 0–3 years similar to those reported 
by Ahmed et al. [21] and Kazemi et al. [22], respectively, who 
observed that 80.6% and 84.2% of the patients with RVGE were 
under 2 years of age. This can be explained by the protective 
effect of maternal antibodies in neonates <6 months old, and the 
development of natural immunity after repeated infections in 
children over 2 years of age.
The male preponderance in acute diarrhea as well as RVGE 
in our study is similar to that reported by Ahmed et al. [19]. The 
explanation for this male predominance remains unclear, and 
this difference bears no statistical significance. Socioeconomic 
status and demographic profile apparently did not influence the 
prevalence of RVGE and NRVGE in the present study, which is 
similar to that reported by Kurugöl et al. [23] from Turkey.
Rotavirus infection occurs all year round but is at peak during 
the winter months. Most studies have observed an increase 
in rotavirus-associated diarrhea during the winter months, 
i.e., October to February, throughout the country ranging from 
59% to 72%, with a median of 64% [15]. The Northern regions 
of India being more temperate may exhibit stronger seasonal 
variation [3]. The occurrence of RVGE apparently did not vary 
with the source of water supply or with access to the sanitary 
lavatory at their homes, similar to the observation made by 
Kurugöl et al. [23] in Turkey.
None of the exclusively breastfed babies had RVGE which 
supports the consensus that breastfeeding is protective as 
compared to top feeding. Kurugöl et al. [23] also observed that 
the majority of the patients (84%) with RVGE were bottle fed. In 
the age group of 6 months–2 years, the proportion of patients with 
adequate complementary feeding was much less as compared to 
those with inadequate complementary feeding in both RVGE and 
NRVGE groups thus emphasizing the importance of adequate 
weaning for prevention of diarrhea as a whole.
The frequency of RVGE in malnourished patients was 
2.5 times (62/78; 75.5%) the frequency of RVGE in patients 
with normal nutritional status (46/132; 34.8%). Thus, it could be 
interpreted that malnourished children were more prone to suffer 
from RVGE as compared to patients with normal nutritional status. 
In contrast, Bern et al. [24] observed no significant difference in 
the prevalence of rotavirus diarrhea and severity of dehydration in 
children with or without malnutrition in Bangladesh.
The majority (97/108; 90%) of the patients with RVGE 
developed dehydration. Dehydration was observed in 87.8%, 
76%, and 43.7% of the patients with RVGE by Modarres 
et al. [25], Shariff et al. [16], and Ahmed et al. [19], respectively. 
Severe dehydration was twice (35.2%) more common in RVGE 
as compared to NRVGE (17.6%). Kurugöl et al. [23] reported 
that severe dehydration was present in approximately two-third 
(69.1%) of patients with RVGE and one-third (39.2%) of the 
patients with NRVGE. Since the nature of the study group has 
not been defined, the results observed in this study cannot be 
compared with the present study.
A purge rate of <10 motions/day was observed in 
approximately two-thirds of the patients with gastroenteritis. 
Fever was observed in three-fourths (82/108; 75.9%) of the 
patients with RVGE in the present study. This was at variance 
with the observations of Modarres et al. [25], Shariff et al. [16], 
and Ahmed et al. [19], who observed fever in 89.4%, 26%, and 
58.4% of RVGE patients, respectively. The average duration of 
illness in RVGE was 4.30±0.91 days which was almost similar to 
NRVGE (4.20±0.81 days) in the present study. However, this was 
in variance with the observation made by Kurugöl et al. [23], who 
reported the average duration of illness in RVGE as 5.5±5.1 days 
and in NRVGE as 3.3±3.1 days.
The limitation of the current study was that it was an 
observational study conducted in a single center with a small 
Table 3: Diarrhea related to clinical symptoms
Clinical characteristics RVGE NRVGE
No. (%) No. (%)
Fever 82 (75.9) 90 (88.2)
Less than 10 loose stools 66 (61.2) 60 (58.8)
10 or more loose stools 42 (38.8) 42 (41.2)
Vomiting 64 (59.3) 80 (78.4)
NRVGE: Non RVGE, RVGE: Rotavirus gastroenteritis
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sample size (due to limited availability of test kit). The data 
from this study will be useful for the policymakers in taking an 
informed decision about the introduction of rotavirus vaccine 
in North India. This study is expected to encourage exclusive 
breastfeeding until 6 months of age besides initiation of timely 
and adequate complementary feeding.
CONCLUSION
The results of our study highlight that rotavirus-associated diarrhea 
is an important and emerging health problem, particularly among 
children <5 years of age. Despite the high prevalence, RVGE can 
successfully and confidently be managed at home and diarrheal 
treatment units in the hospitals thereby reducing the number of 
referrals of gastroenteritis cases from peripheries to tertiary care 
hospitals which always remain over occupied.
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